Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Carlsmed (CARL) Total Non-Current Liabilities (2024 - 2025)

Carlsmed (CARL) has disclosed Total Non-Current Liabilities for 2 consecutive years, with $30.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Total Non-Current Liabilities rose 20.07% year-over-year to $30.9 million, compared with a TTM value of $30.9 million through Dec 2025, up 20.07%, and an annual FY2025 reading of $30.9 million, up 20.07% over the prior year.
  • Total Non-Current Liabilities was $30.9 million for Q4 2025 at Carlsmed, up from $27.9 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $30.9 million in Q4 2025 and bottomed at $25.8 million in Q4 2024.